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Autocrine and paracrine functions of vascular endothelial
growth factor (VEGF) in renal tubular epithelial cells.
Background. VEGF secreted by organ parenchymal cells
controls vascularization by recruiting endothelial cells and sup-
porting their proliferation. In the developing kidney VEGF-
expressing epithelial cells also express VEGF receptors. We
showed that VEGF stimulates tubulogenesis in addition to pro-
moting vascularization in metanephric explants. Since explants
are grown in serum-free media and are not perfused, we hy-
pothesized that VEGF secreted by renal epithelia may induce
their proliferation in an autocrine manner and chemoattract
endothelial cells.
Methods. To test these hypotheses, we analyzed VEGF-
mediated responses in vitro using several renal epithelial
cell lines [immortalized rat proximal tubular cells (IRPT),
transformed mouse proximal tubular cells (tsMPT), and nor-
mal rat kidney cells (NRK-52E)] expressing VEGF receptors
(VEGFR).
Results. We demonstrated that VEGFR-2 phosphorylates
upon human recombinant VEGF (rhVEGF) exposure, indi-
cating that VEGFR-2 is the signaling receptor. All three cell
lines secreted VEGF into the media as indicated by enzyme-
linked immunosorbent assay (ELISA) and Western blotting.
We showed that these tubular epithelial cells chemoattract en-
dothelial cells when cocultured in vitro and that the chemoat-
traction is abolished by anti-VEGF neutralizing antibody.
rhVEGF (10 ng/mL) induced a mitogenic effect similar to 10%
fetal bovine serum (FBS) as assessed by H3-thymidine incorpo-
ration and elicited 30% decrease in apoptosis as determined by
annexin V-fluorescein isothiocyanate (FITC) staining.
Conclusion. These in vitro studies indicate that (1) tubular ep-
ithelial cells chemoattract endothelial cells in a paracrine fash-
ion by secreting VEGF, and (2) VEGF stimulates proliferation
and promotes survival of renal epithelial cells in an autocrine
manner via VEGFR-2. Taken together, our results suggest that
VEGF supports the growth of renal epithelia in addition to me-
diating kidney vascularization.
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Vascular endothelial growth factor-A (VEGF) is a po-
tent angiogenic factor required for vascular development
[1–3]. VEGF is expressed in multiple organs and cell
types, notably parenchymal cells adjacent to capillaries
and vascular cells adjacent to endothelia [4, 5]. Known
functions of VEGF demonstrated in vitro are induction
of endothelial cell proliferation, survival, and directional
migration [6]. VEGF signaling is mediated by tyrosine
kinase receptors VEGFR-1 and VEGFR-2, previously
known as Flt-1 and Flk-1 and coreceptors neuropilins 1
and 2 (NP-1 and NP-2) that are expressed mostly by en-
dothelial cells and their precursors [7–10]. Expression of
VEGF receptors in other cell types has also been docu-
mented in vivo and in vitro [5, 6, 11–13]. Although the
function of VEGF receptors in these cell types remains
poorly understood, they are thought to transduce VEGF-
dependent proliferation and survival signals [14–16].
In the kidney, VEGF plays a fundamental role in the
formation of the glomerular vascular tuft during develop-
ment [17, 18]. In addition, it is likely that VEGF controls
the differentiated properties of the glomerular capillar-
ies including their fenestrated phenotype [19]. Much less
is known about the role of VEGF in regulating renal
epithelial growth during development. We showed that
VEGF induces tubulogenesis in metanephric explants [5,
17].VEGF expression is developmentally regulated [5].
VEGF is expressed in S-shaped bodies and, as nephron
differentiation proceeds, in podocytes and renal tubular
epithelial cells [5, 14, 20]. Although the overall level of
expression decreases in the adult kidney as compared to
the embryonic one, VEGF continues to be expressed in
podocytes and distal tubular epithelial throughout adult
life [5, 20].We hypothesized that VEGF secreted by renal
epithelia may induce their proliferation in an autocrine
manner and chemoattract endothelial cells, thereby play-
ing a role in proportioning nephron and vascular bed mass
and determining the spatial organization of the vascula-
ture. To address these hypotheses in vitro we examined
the expression and function of VEGF and its receptors
in several renal tubular epithelial cell lines [21]. Re-
sults of these experiments confirm our observations using
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metanephric kidney explants [5, 17]. VEGF secreted by
cultured renal epithelial cell lines functions in an au-
tocrine fashion inducing these cells to proliferate and in
a paracrine manner attracting endothelial cells. VEGF
signals are mediated by VEGFR-2.
METHODS
Cell culture
Mouse- and rat-transformed proximal tubular epithe-
lial cells, tsMPT [21] and IRPT [22], were grown in Dul-
becco’s modified Eagle’s medium (DMEM) with 10% fe-
tal bovine serum (FBS) in nonpermissive conditions, and
rat nontransformed tubular epithelial cells (NRK-52E)
[23] were grown in DMEM medium with low CO3HNa
and 5% FBS. All cell types were maintained at 37◦C
in 95% air/5% CO2 (20% O2) or 3% O2/92% N2/5%
CO2 (3% O2) as indicated. FBS was removed from
the media 12 hours before the experiments unless oth-
erwise indicated and cells were washed twice with
phosphate-buffered saline (PBS) immediately prior to all
experiments.
Immunocytochemistry
Tubular epithelial cells were plated on glass slides and
grown as described above, fixed with 2% paraformalde-
hyde, washed with PBS, blocked with goat serum, and
incubated with anti-VEGF (PC37) (Calbiochem, San
Diego, CA, USA), anti-Flt-1 (SC #316) (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), anti-Flk-1 (SC
#315) (Santa Cruz Biotechnology), anti-NP-1, and anti-
NP-2 (kindly provided by Alan Kolodkin) polyclonal an-
tibodies at room temperature for 60 minutes or overnight
at 4◦C. Secondary antibody was biotinylated antirabbit
IgG. Reactions were detected by the ABC technique
(Vector Laboratories, Burlingame, CA, USA) using alka-
line phosphatase as a substrate. Negative controls were
absent primary antibodies, competition with specific pep-
tide, and replacement of primary antibody by preimmune
serum. Cells were mounted with water-soluble mount-
ing media with or without DAPI (Vectashield; Vector
Laboratories) and examined by fluorescent microscopy
(Nikon Eclipse E400, Columbia, MD, USA). In addi-
tion, VEGFR-2 was detected in embryonic kidney sec-
tions by immunoperoxidase using the ABC technique as
described [3] and examined by light microscopy.
Western blotting and immunoprecipitation
Cells were grown as described above on plastic to
80% confluence, washed, stimulated with 10 to 50 ng/
mL human recombinant VEGF (rhVEGF) (R&D Sys-
tems, Minneapolis, MN, USA) as indicated and lysed in
modified RIPA buffer [150 mmol/L NaCl, 1.5 mmol/L
Cl2Mg, 5 mmol/L NaP2O7, 20 mmol/L Hepes, 0.2% Tri-
ton X-100, 10% glycerol, 5 mmol/L ethylenediaminete-
traacetic acid (EDTA), 50 mmol/L NaF, and 2 mmol/L
Na3VO4] with complete EDTA-free protease inhibitor
cocktail (Roche Diagnostics, Indianapolis, IN, USA).
Protein concentration was determined using the bicin-
choninic acid assay (Sigma, St. Louis, MO, USA) follow-
ing the manufacturer’s instructions. From 100 to 300 lg
protein was resolved in 15% or 7% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
(for VEGF and its receptors, respectively), transferred to
nitrocellulose membranes (Trans-blot Transfer Medium)
(Bio-Rad, Hercules, CA, USA) and blotted with anti-
VEGF, anti-Flt-1, anti-Flk-1 (Santa Cruz Biotechnol-
ogy), phosphorylation specific anti-Flk-1 antibody (Cell
Signaling Technologies, Beverly, MA, USA) anti-VEGF
antibody (PC-37) (Oncogene, Cambridge, MA, USA),
antiphosphotyrosine antibody (clone G410) Upstate
Biotechnology, Charlottesville, VA, USA), anti-bcl-2
(#610538) (BD Biosciences, San Diego, CA, USA),
anti-Akt (#610860) (BD Biosciences), antiphospho-
Akt (Ser473) (#9271) (Cell Signaling), anti-SV40 large
and small T antigens (DP02 and DP14L) (Onco-
gene) antibodies. Signals were detected with horseradish
peroxidase (HRP)-conjugated secondary antibodies
and enhanced chemiluminescence (ECL) (Amersham,
Piscataway, NJ, USA) according to the manufacturer’s
instructions. In immunoprecipitation experiments 1.5 mg
protein from cell lysates was incubated with antiphospho-
tyrosine antibody (clone G410) (Upstate Biotechnology),
protein A agarose beads (Roche) were added overnight,
washed four times with lysis buffer and boiled in 2×
sample buffer (0.125 mol/L Tris-HCl, pH 6.8, 4% SDS,
20% glycerol, and 10% 2-mercaptoethanol). Immuno-
precipitates were resolved in 7% SDS-PAGE, transferred
to nitrocellulose membranes, and immunoblotted with
antiphospho-Flk-1 (Cell Signaling) and anti-Flk-1 (Santa
Cruz Biotechnology) antibodies. Protein expression was
quantified by densitometric analysis using ImageQuant
(Molecular Dynamics, Sunnyvale, CA, USA).
VEGF secretion
VEGF concentration in the cell supernatant and in
media + 10% FBS was measured by enzyme-linked im-
munosorbent assay (ELISA) using mVEGF Quantikine
(R&D Systems) following the manufacturer’s instruc-
tions. Duplicate 50 lL samples from control (fresh media)
and supernatant after 24 hours culture in 95% air/5%CO2
were examined from all cell types. In addition, super-
natants were concentrated (×60) and 50 lL samples were
resolved in 12% SDS-PAGE gels, transferred and im-
munoblotted with anti-VEGF antibody (Oncogene). In
additional experiments, supernatant samples from cells
exposed to 3% O2/92% N2/5% CO2 (hypoxia) or 95%
air/5% CO2 (normoxia) for 24 hours were examined in
duplicate by ELISA.
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Coculture and migration assay
A total of 2 × 104 IRPT, tsMPT, or NRK-52E cells
were plated on top of 1 mg/mL collagen I gels (BD Bio-
sciences), allowed to attach for 2 hours and cocultured
with 3 × 104 mouse glomerular endothelial cells (MGEC)
[17]. All epithelial-MGEC cocultures were maintained in
MGEC media (MDCB131) (Sigma), 15% FBS, 50 lg/mL
heparin, 150 lg/mL endomitogen, and 1 ng/mL epidermal
growth factor (EGF), 50 U/mL pen/strep with or without
2 lg/mL anti-VEGF neutralizing antibody (R&D Sys-
tems) for 72 hours. Cocultures were imaged at 12, 24, 48,
and 72 hours using a phase-inverted microscope (Nikon
TMS; Nikon).
Cell proliferation assay
Cell proliferation was examined by H3-thymidine in-
corporation assay. Briefly, 5 × 104 IRPT and tsMPT
cells were plated on 6-well plates, allowed to attach
for 12 hours, serum starved for 12 hours, and exposed
to H3-thymidine (1 lCi/mL) for 6 hours in the pres-
ence of rhVEGF (1, 5, 10, or 50 ng/mL), media alone,
media + 10% FBS, media + anti-VEGF neutralizing
antibody (2 lg/mL) (R&D Systems), media +soluble
chimeric Fc-NP-1 (2.5 lg/mL) (R&D Systems), or media
+ chimeric Fc-Flk-1 (1.5 lg/mL) (R&D Systems) with
and without VEGF (10 ng/mL). After 6 hours incubation
at 37◦C in a 95% air, 5% CO2 incubator, cells were thor-
oughly washed with PBS, detached with trypsin-EDTA
and DNA was precipitated with cold 15% trichoroacetic
acid (TCA) overnight at 4◦C and H3-thymidine incorpo-
ration counted on a scintillation counter (Beckman LS
6500; Beckman Coulter, Inc., Fullerton, CA, USA).
Apoptosis
Apoptosis was assessed by annexin V-fluorescein isoth-
iocyanate (FITC) (Molecular Probes, Eugene, OR, USA)
and propidium iodide binding assays [24]. Briefly, 2.5 ×
105 cells were plated in 6-well plates for 24 hours,
tsMPT and IRPT cells were serum-starved for 48 hours.
rhVEGF165 (10 ng/mL) (R&D Systems) was added to all
cell types. Controls were media + 0.1% bovine serum al-
bumin (BSA), media + 10% FBS, and media + 50 ng/mL
cycloheximide (Sigma). After 24-hour incubation cells as
well as media containing detached cells were harvested.
Cells were stained with propidium iodide (Sigma) and an-
nexin V-FITC according to manufacturer’s specifications.
The number of apoptotic, necrotic, and viable cells was
determined by flow cytometry (FACSCalibur) (Becton-
Dickinson, Sunnyvale, CA, USA). Cells positive for an-
nexin V-FITC were assessed as apoptotic. Cells stained
with both propidium iodide and annexin V-FITC were
considered late apoptotic or necrotic. Cells negative for
both stainings were deemed viable.
Statistical analysis
Experiments were performed at least three times, the
number for each of them is indicated in the correspond-
ing figure legend. In ELISA experiments, results from
duplicate samples were averaged and data are expressed
as mean ± SEM (N ≥ 4) for each condition. In H3-
thymidine incorporation experiments, data are expressed
as mean ± SEM-fold increase from control conditions. In
apoptosis experiments four experiments for each cell type
were analyzed, samples were examined in duplicate, re-
sults averaged and expressed as mean ± SEM percentage
change from control conditions. Densitometric data from
Western blot analysis of three or more independent ex-
periments are expressed as mean ± SEM-fold changes in
protein expression levels. Control and experimental con-
ditions were compared using unpaired t test or analysis
of variance (ANOVA) as appropriate. Statistical signifi-
cance was defined as P < 0.05.
RESULTS
Tubular epithelial cells express VEGF and its receptors
Western blot analysis showed that the three renal tubu-
lar cell lines express VEGF at similar levels (Fig. 1A).
Fluorescent immunocytochemistry showed that VEGF
localizes to the cytoplasm of the tubular cells (Fig. 1B).
VEGF receptors Flt-1, Flk-1, and coreceptors NP-1 and
NP-2 are expressed by tubular epithelial cell lines as
shown by immunocytochemistry (Fig. 2A). Localization
of VEGF receptors in tubular epithelial cell lines mimics
their presence in developing tubular epithelia (Fig. 2B).
Western blot analysis showed expression of Flt-1 and
Flk-1 with 180 and 200 kD bands, respectively, that cor-
respond to the size of these receptors in glomerular
endothelial cells (Fig. 2C). IRPT, tsMPT, and NRK-52E
cells also express NP-1 and NP-2, as we previously re-
ported ([13] and data not shown).
To determine whether VEGF receptors are functional
in these renal epithelial cells we examined Flk-1 and
Flt-1 phosphorylation upon VEGF binding by immuno-
precipitation and immunoblotting. Upon exposure to 10
to 50 ng/mL VEGF, Flk-1 phosphorylation increased sig-
nificantly above control within 5 minutes and declined
after 15 minutes (Fig. 2D). VEGF-induced phosphoryla-
tion of Flt-1 was not detected in any of the epithelial cell
lines studied (data not shown). These results suggest that
Flk-1 is the VEGF signaling receptor in tubular epithelial
cells.
VEGF secretion by renal tubular epithelial cells
To examine whether renal epithelial cells are able to
secrete VEGF we first measured VEGF concentration in
their supernatant by ELISA. In normoxia, IRPT, tsMPT,
and NRK-52E cells secreted VEGF to the media (120 ±
12.0, 9 ± 4.4, and 79 ± 14.0 pg/mL, respectively) (Fig. 3A).
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Fig. 2. Expression of vascular endothelial growth factor (VEGF) receptors in IRTP, tsMPT, and NRK-52E cells. (A) Flt-1, Flk-1, NP-1 and NP-2
receptors are detected in cell membrane and perinuclear regions (red) by fluorescent immunocytochemistry in the three cell lines. (B) Embryonic
day 17 rat kidney section showing immunostaining for Flk-1 in the tubular portion two S-shaped bodies. (C) Flk-1 and Flt-1 expression examined by
Western blotting showed ∼200 kD and ∼180 kD bands, respectively. Mouse glomerular endothelial cell lysate (MGEC) is shown as positive control.
(D) Epithelial cells were exposed to VEGF (10 to 50 ng/mL) for 2, 5, or 15 minutes, anti-phosphotyrosine (PY) immunoprecipitates were prepared
and immunoblotted with phospho-specific anti-Flk-1 antibody or lysates were immunoblotted with anti-Flk1 and anti-PY antibodies (NRK-52E).
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Fig. 1. Vascular endothelial growth factor (VEGF) expression in
tubular epithelial cells. (A) Confluent IRTP, tsMPT, NRK-52E and
mouse glomerular endothelial cells (MGEC) were lysed, 100 lg pro-
tein/lane was resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotted with anti-VEGF an-
tibody as detailed in the Methods section. Molecular weight makers are
indicated on the left, VEGF isoforms are indicated on the right. (B)
VEGF (red) is detected in the cytoplasm of IRPT, tsMPT and NRK-
52E cells by fluorescent immunocytochemistry, nuclei are labeled by
DAPI stain (blue) in some of them.
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Fig. 3. Vascular endothelial growth factor (VEGF) secretion by tubu-
lar epithelial cells. (A) VEGF concentration was measured by enzyme-
linked immunosorbent assay (ELISA) in supernatant from IRTP,
tsMPT, and NRK-52E cells grown to confluence 24 hours after me-
dia change in normoxia (gray bar) and hypoxia (open bar). Data are
expressed as mean ± SEM (N = 8). ∗P < 0.05. (B) VEGF content in
concentrated supernatant, two isoforms VEGF164 and VEGF121 are
detected by Western blotting.
When exposed to hypoxia IRPT, tsMPT, and NRK-52E
cells significantly increased VEGF secretion to the media
(386 ± 67.5, 20 ± 1.9, and 158 ± 16.1 pg/mL, respectively)
(Fig. 3A), indicating that VEGF secretion is regulated by
hypoxia.
To determine which VEGF isoforms were secreted, we
concentrated the supernatants of all cell lines and exam-
ined them by western blotting. As shown in Figure 3B,
all tubular epithelial cells secreted two VEGF isoforms,
corresponding to VEGF164 and VEGF120.
Fig. 4. IRPT, tsMPT and NRK-52E cells attract mouse glomerular en-
dothelial cells (MGEC). Epithelial cells and MGEC were grown on
collagen I gels. (A) After 12 hours, coculture MGEC cells migrate to-
ward tsMPT, IRPT, and NRK-52E cells (tsMPT cell shown here). (B)
After 72 hours, coculture IRPT, tsMPT, and NRK-52E cells form large
clusters surrounded by MGEC cells (tsMPT cells shown here). Asterisk
indicates endothelial cell, arrowhead indicates epithelial cell.
VEGF-secreting epithelial cells attract endothelial cells
As a result of VEGF secretion a concentration gradient
may be established from the cell outward. Such a concen-
tration gradient could serve as a chemoattractive guid-
ance cue for endothelial cells. To test this hypothesis, we
cocultured MGEC and each one of the epithelial cell lines
on collagen I gels. After 12 hours of coculture, tsMPT,
NRK-52E, and IRPT cells attracted MGEC (Fig. 4A).
After 72 hours in coculture, tsMPT, NRK-52E, and IRPT
cells formed clusters of epithelial cells surrounded by en-
dothelial cells (Fig. 4B). Thus, VEGF-secreting tubular
epithelial cells are able to attract endothelial cells to-
ward them. MGEC chemoattraction by epithelial cells
was prevented by anti-VEGF neutralizing antibody (data
not shown). These data indicate that one of VEGF’s func-
tions in renal epithelial cells is to attract endothelial cells
in a paracrine manner.
VEGF induces renal epithelial cell proliferation
We examined VEGF’s ability to induce tubular epithe-
lial cell proliferation by measuring H3-thymidine incor-
poration in the absence of serum and in the presence
of increasing doses of rhVEGF (1 to 50 ng/mL). VEGF
induced a two- to threefold increase in H3-thymidine in-
corporation in IRPT and tsMPT cells, which was max-
imal at a concentration of 10 ng/mL and similar to that
induced by 10% FBS (Fig. 5). VEGF concentration in me-
dia + 10% FBS was 335 pg/mL. Thus, 10 ng/mL VEGF
in the absence of serum induced a mitogenic effect sim-
ilar to 335 pg/mL VEGF provided by 10% FBS. Anti-
VEGF neutralizing antibody and chimeric receptors
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Fig. 5. Vascular endothelial growth factor (VEGF) stimulates tubu-
lar epithelial cell proliferation. (A) Subconfluent cultures of epithelial
cells were incubated with media, media + VEGF (10 ng/mL) or media
+ 10% fetal bovine serum (FBS) for 6 hours in the presence of 1 lCi/mL
H3-thymidine. (B) Subconfluent cultures of epithelial cells were incu-
bated with media or media + different concentrations of VEGF (5 to
50 ng/mL) for 6 hours in the presence of 1 lCi/mL H3-thymidine. The
values shown represent the mean ± SEM-fold increase above control
cpm readings (N = 7) (A) and (N = 4) (B). ∗P < 0.05 VEGF vs. control.
Flk-1 and NP-1 prevented rhVEGF-induced H3-
thymidine incorporation (data not shown) and decreased
baseline H3-thymidine incorporation by 10 ± 3.3%.
These data indicate that VEGF has an autocrine mito-
genic effect on renal epithelial cells.
VEGF promotes renal epithelial cell survival by reducing
apoptosis through the Akt signaling pathway
We examined whether VEGF plays a role in renal ep-
ithelial cell survival by preventing or reducing apopto-
sis induced by serum starvation for 48 hours. rhVEGF
(10 ng/mL) elicited a significant decrease in apoptosis
of approximately 30% in IRPT and tsMPT (Fig. 6). As
expected, cycloheximide induced several-fold increase in
apoptosis (positive control) and FBS prevented apoptosis
(negative control). These data suggest that VEGF plays a
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Fig. 6. Vascular endothelial growth factor (VEGF) reduces apoptosis
in tubular epithelial cells. Confluent epithelial cell cultures were serum
starved for 48 hours and incubated with serum-free media, media +
fetal bovine serum (FBS), media +VEGF (10 ng/mL), or media + cy-
cloheximide (50 ng/mL) for 24 hours. Annexin-V binding to apoptotic
cells was assessed by flow cytometry as detailed in the Methods section.
The results shown represent mean ± SEM percent changes from con-
trol (serum-free media) (N = 4 for each cell type). ∗P < 0.05 VEGF vs.
control.
modest role in renal epithelial cell survival that becomes
important under significant cell stress.
To determine the mechanism involved in the reduced
apoptosis induced by VEGF, we examined the Akt/bcl-2
pathway. VEGF increased Akt phosphorylation twofold
in IRPT, tsMPT, and NRK-52E cells (Fig. 7A), indicating
VEGF-mediated induction of the kinase activity. How-
ever, bcl-2 or total Akt expression levels were not altered
by VEGF exposure for 8 to 24 hours (Fig. 7B).
DISCUSSION
The present studies demonstrate that renal tubular ep-
ithelial cell lines have complete and functional VEGF
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Fig. 7. Vascular endothelial growth factor (VEGF) induces Akt phos-
phorylation but does not regulate total bcl-2 and Akt protein expression
in renal tubular epithelial cells. Confluent epithelial cells were incubated
in media (control) or media + VEGF (10 ng/mL) for the indicated
times. Cell lysates were prepared, resolved and immunoblotted with
antibodies to bcl-2, Akt, and phosphorylated-Akt. (A) Time course of
Akt phosphorylation. (B) Akt and bcl-2 protein expression. The blots
shown are representative of three independent experiments. The size of
bcl-2 (26 kD) and Akt (59 kD) are indicated on the right and the molec-
ular markers are indicated on the left. Densitometric analysis showed
a significant twofold increase in Akt phosphorylation upon VEGF ex-
posure, whereas Akt and bcl-2 expression level remained stable.
systems with autocrine and paracrine functions. VEGF’s
autocrine functions in these cell lines include induction
of proliferation and survival. The paracrine function of
VEGF-secreting renal tubular epithelial cells is to attract
endothelial cells.
Although initially thought to be expressed exclusively
in endothelial cells, VEGF receptors and coreceptors
have been identified in several nonendothelial cells and
tissues, including the tubules of embryonic and adult nor-
mal kidneys [5, 6, 12–14]. Because these epithelial cells
also produce VEGF, elucidation of the role of putative
autocrine VEGF systems in vitro is relevant to a bet-
ter understanding of their function in vivo. The three re-
nal tubular epithelial cell lines studied express VEGF,
VEGFR-1 and VEGR-2 and the coreceptors NP-1 and
NP-2, as indicated by immunohistochemistry and West-
ern blot analysis. In agreement with previous findings
[14], VEGF receptor immunostaining was detected in the
cell membranes, in developing tubules and to a lesser ex-
tent, in the cytoplasm of renal tubular epithelial cells. This
localization of VEGF receptors was only partially pre-
vented by omitting permeabilization and using various
fixatives; thus, we believe it is unlikely to be an artifact.
We demonstrated that VEGFR-2 phosphorylates upon
VEGF exposure by immunoprecipitation with antiphos-
photyrosine antibody followed by immunoblotting with
anti-VEGFR-2 antibody and by immunoblotting with an-
tiphosphorylation specific VEGFR-2 antibody (data not
shown). VEGF-induced phosphorylation of VEGFR-2
suggests that VEGFR-2 is the signaling receptor medi-
ating autocrine VEGF functions in the renal tubular ep-
ithelial cell lines examined.
Little is known about how capillaries develop ad-
jacent to parenchymal epithelial cells during kidney
organogenesis. We previously showed that embryonic
kidneys produce VEGF and attract exogenous endothe-
lial cells toward developing nephrons [5, 25]. To deter-
mine whether renal tubular cell lines are able to establish
a VEGF concentration gradient and thereby attract en-
dothelial cells we assessed their ability to secrete VEGF.
All tubular epithelial cells examined secrete VEGF as de-
tected by ELISA and Western blotting. The magnitude
of VEGF secretion varied among the epithelial cell lines
examined and remained in the picogram per milliliter
range due to the dilution factor from the culture media
(≥ ×50), should the media volume be minimal as if it
were interstitial fluid, the concentration would have been
in the nanogram per milliliter range. The mechanism(s)
underlying the observed differences in VEGF secretion
between these cell lines are unknown. It has been re-
ported that the SV40 large T antigen induces expression
of VEGF in mesothelial cells whereas its small t anti-
gen does not [26]. We studied IRPT and tsMPT at the
nonpermissive temperature, in this condition the large T
antigen should not be expressed [21, 22]. However, SV40-
T and t antigens were expressed by IRPT and tsMPT
cells (data not shown). VEGF secretion by IRPT cells
was higher than that of the other two cell lines regard-
less of whether they were transformed cells (tsMPT) or
not (NRK-52E). To determine whether VEGF secretion
was regulated, which would be unlikely if driven by viral
antigens, we compared VEGF secretion in normoxic and
hypoxic conditions and determined that VEGF secretion
was up-regulated by hypoxia in the three tubular epithe-
lial cell lines studied. Taken together, these data suggest
that, similar to NRK-52E, the observed VEGF secretion
is the natural behavior of IRPT and tsMPT cells rather
than a consequence of their viral transformation.
VEGF-secreting cells can generate a concentration
gradient because the larger VEGF isoforms are mem-
brane and extracellular matrix bound and only VEGF120
is fully diffusible [27]. Accordingly VEGF164 and
VEGF120 were detected in the media whereas VEGF188
and VEGF164 were detected in cell lysates (Figs. 1A and
3B, respectively). Our coculture experiments showed that
VEGF-secreting cells attract endothelial cells, suggesting
that endothelial cells migrate following a VEGF gradi-
ent. IRPT, tsMPT, and NRK-52E cells similarly attracted
MGECs within a few hours and later formed epithelial
cell conglomerates surrounded by the endothelial cells.
VEGF was initially thought to be a specific endothe-
lial cell mitogen [28, 29]. More recent studies showed that
VEGF also stimulates proliferation of other cell types [14,
15, 30–32]. We previously showed that VEGF induces
456 Villegas et al: Functions of VEGF in tubular epithelial cells
tubulogenesis in the metanephric organ culture model
[17]. In the present study we show that VEGF stimu-
lates proliferation of IRPT and tsMPT cells in a dose-
response manner. The maximal VEGF mitogenic effect
is similar to that of 10% FBS. Our results are in agree-
ment with a previous report using NRK-52E cells [14].
When anti-VEGF neutralizing antibody or the receptor
chimeras was added to cells grown in control media the
incorporation of H3-thymidine decreased by about 10%,
suggesting that about the same percentage of the base-
line mitotic rate of these cell lines could be attributed to
a VEGF autocrine effect. This effect may be trophic and
become quantitatively more important when VEGF is
up-regulated, such as in hypoxia. Recent studies demon-
strated a fundamental role for VEGF signaling in liver
and pancreas parenchymal induction and development
[30–33]. VEGF’s growth promoting effects on hepato-
cytes require endothelial cell paracrine mediators [15].
Whether VEGF induces renal epithelial cell prolifera-
tion directly or indirectly via up-regulation of epithelial
growth factor(s) is unclear.
VEGF is a survival factor for endothelial cells that de-
creases apoptosis via the phosphatidylinositol 3′-kinase
(PI3K)-Akt signaling pathway and induction of bcl-2 [18,
33, 34]. A VEGF-mediated decrease in apoptosis has also
been described in other cell types [35], including NRK-
52 renal tubular cells [14]. Kanellis et al [14] showed an
increase in survival of NRK-52 cells when exposed to
hydrogen peroxide and pharmacologic doses of recom-
binant VEGF (100 ng/mL). In the present study, VEGF-
induced survival effect was tested after serum starvation
using a lower VEGF dose (10 ng/mL) consistent with the
concentration at which all receptors are fully saturated
[7, 8]. Under these conditions a modest increase in IRPT
and tsMPT cell survival of about 30% was observed, sim-
ilar to that induced by FBS. The decrease in apoptosis
induced by VEGF was associated with and possibly me-
diated by Akt phosphorylation without change in total
Akt or bcl-2 expression level between 8 and 24 hours,
suggesting that Akt activity is involved in VEGF-induced
protection from apoptosis in these renal epithelial cells.
CONCLUSION
We demonstrated in vitro that tubular epithelial cells
have complete and functional VEGF systems by identify-
ing the expression of the ligand and its receptors, VEGF
secretion, VEGF-induced phosphorylation of VEGFR-
2 and a signaling partner as well as VEGF’s autocrine
and paracrine functions. VEGF stimulates proliferation
and promotes survival of renal epithelial cells in an au-
tocrine manner via VEGFR-2 and Akt signaling pathway.
VEGF-secreting tubular epithelial cells chemoattract en-
dothelial cells in a paracrine fashion.
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